To: Svartalfiar
How was it "under-tested?" It went through the same clinical trials as everything else. It just didn't take five years to do it. How wasn't it? What long-term trials were done? How much animal testing was completed?
The safety of Moderna COVID‑19 Vaccine was evaluated in an ongoing Phase 3 randomized, placebo-controlled, observer-blind clinical trial conducted in the United States involving 30,351 participants 18 years of age and older who received at least one dose of Moderna COVID‑19 Vaccine (n=15,185) or placebo (n=15,166) (NCT04470427). I would call that pretty thorough testing.
To: eastexsteve
The safety of Moderna COVID‑19 Vaccine was evaluated in an ongoing Phase 3 randomized, placebo-controlled, observer-blind clinical trial conducted in the United States involving 30,351 participants 18 years of age and older who received at least one dose of Moderna COVID‑19 Vaccine (n=15,185) or placebo (n=15,166) (NCT04470427). I would call that pretty thorough testing.
So it's ongoing. Which means they don't even have results from that testing yet, besides "no one died immediately". Actual results haven't been published, much less even acquired. That's not "thorough testing" if it hasn't been completed yet!
And 15M people is a decent group, but still not that large for looking at many of the possible drug/other disease combinations. Who received at least one dose, meaning many of them haven't even gotten the full suggested dose yet! And speaking of dosages, how many of these people are getting different dosages? Are they still testing how much to give? Or are they at least past that mid-process step?
What about the other drugs? Has Pfizer or JnJ or any of the foreign ones gotten a 'large' Guinea pig group like this one? All of these are getting millions of shots thrown around, and they're somehow the fastest drugs to ever go through the RnD process, despite not just being a new vaccine, but on entirely new type of drug!
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson